EDIT Stock Summary and Trading Ideas (Editas Medicine | NASDAQ:EDIT)

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

What symbol and exchange does Editas Medicine shares trade?

Editas Medicine trades on the NASDAQ stock market under the symbol EDIT.

What is Editas Medicine stock price doing today?

As of April 24, 2026, EDIT stock price declined to $2.91 with 1,453,412 million shares trading.

What is Editas Medicine's Beta?

EDIT has a beta of 2.33, meaning it tends to be more sensitive to market movements. EDIT has a correlation of 0.14 to the broad based SPY ETF.

How much is Editas Medicine worth?

EDIT has a market cap of $284.07 million. This is considered a Small Cap stock.

How much money does Editas Medicine make?

Last quarter Editas Medicine reported $25 million in Revenue and -$.06 earnings per share. This beat revenue expectation by $17 million and exceeded earnings estimates by $.18.

What is the highest and lowest price Editas Medicine traded in the last 3 year period?

In the last 3 years, EDIT traded as high as $11.91 and as low as $.91.

What are the top ETFs holding Editas Medicine?

The top ETF exchange traded funds that EDIT belongs to (by Net Assets): VTI, IWM, IWN, VXF, IBB.

Is Editas Medicine (EDIT) a good investment?

EDIT has outperformed the market in the last year with a return of +80.7%, while the SPY ETF gained +31.9%. In the last 3 month period, EDIT beat the market returning +34.7%, while SPY returned +3.8%. However, in the most recent 2 weeks EDIT has underperformed the stock market by returning -1.0%, while SPY returned +5.1%.

What are the support and resistance levels for Editas Medicine (EDIT)?

EDIT support price is $3.03 and resistance is $3.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EDIT shares will trade within this expected range on the day.